Review of Questions Concerning Clinical Drug Interactions in ADHD Treatment From Physicians in Norway
Pharmacological treatment of attention deficit hyperactivity disorder (ADHD) is challenging due to a wide age span among patients, risk of reduced adherence, and comorbidities like psychiatric disorders and drug addiction. Drugs used for ADHD are associated with risk of interactions and adverse drug...
Main Authors: | Jan Schjøtt, Kristine Heitmann, Tina Bakkebø, Jan Anker Jahnsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.607915/full |
Similar Items
-
Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres
by: Jan Anker Jahnsen, et al.
Published: (2018-01-01) -
Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers
by: Jahnsen JA, et al.
Published: (2021-07-01) -
Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View
by: Sahrai Saeed, et al.
Published: (2021-06-01) -
Neurofeedback in ADHD/ADD treatment
by: Rok Holnthaner
Published: (2008-04-01) -
Visual neglect in ADHD students
by: Diamond, Susan J.
Published: (2017)